Yu Hongsheng News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Yu hongsheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Yu Hongsheng Today - Breaking & Trending Today
Pressurized refining system at Biyang Huifeng Wood Industry Board's MDF production plant in Henan province, China started up by ANDRITZ news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.
Bold, persistent reforms forge ahead under Xi s leadership Pub Date:20-12-18 08:42 Source:Xinhua Coronary stents, used to treat coronary heart disease, were once priced at about 13,000 yuan (1,989 U.S. dollars) each in China. Now they are expected to cost patients only 700 yuan on average. The massive price slash ensued from the initial round of the Chinese government s centralized procurement program for high-value medical consumables in early November. The program, which aims to bring down the pricing by large-scale purchasing and squeezing out multiple layers of agent middlemen, owes its origin to Sanming, an industrial city with a permanent population of ....
FUZHOU, Dec. 17 (Xinhua) Coronary stents, used to treat coronary heart disease, were once priced at about 13,000 yuan (1,989 U.S. dollars) each in China. Now they are expected to cost patients only 700 yuan on average. The massive price slash ensued from the initial round of the Chinese government s centralized procurement program for high-value medical consumables in early November. The program, which aims to bring down the pricing by large-scale purchasing and squeezing out multiple layers of agent middlemen, owes its origin to Sanming, an industrial city with a permanent population of 2.6 million in east China s Fujian Province. ....
2020-12-18 02:11:15 GMT2020-12-18 10:11:15(Beijing Time) Xinhua English Coronary stents, used to treat coronary heart disease, were once priced at about 13,000 yuan (1,989 U.S. dollars) each in China. Now they are expected to cost patients only 700 yuan on average. The massive price slash ensued from the initial round of the Chinese government s centralized procurement program for high-value medical consumables in early November. The program, which aims to bring down the pricing by large-scale purchasing and squeezing out multiple layers of agent middlemen, owes its origin to Sanming, an industrial city with a permanent population of 2.6 million in east China s Fujian Province. ....
Xi Focus: Bold, persistent reforms forge ahead under Xi's leadership - Xinhua xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.